To get better insight into the management of non-metastatic castration-resistant prostate cancer (M0 CRPC), in this meta-analysis and review we aimed to present an updated evaluation of the efficacy and safety of novel hormonal therapies (nHT) for M0 CRPC according to final analyses with mature overall survival (OS) and safety data.

A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data / Maggi, Martina; Salciccia, Stefano; Del Giudice, Francesco; Busetto, Gian Maria; Falagario, Ugo G; Carrieri, Giuseppe; Ferro, Matteo; Porreca, Angelo; Di Pierro, Giovanni Battista; Fasulo, Vittorio; Frantellizzi, Viviana; De Vincentis, Giuseppe; De Berardinis, Ettore; Sciarra, Alessandro. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 11:(2021). [10.3389/fonc.2021.700258]

A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data

Maggi, Martina
Primo
;
Salciccia, Stefano
Secondo
;
Del Giudice, Francesco;Busetto, Gian Maria
;
Di Pierro, Giovanni Battista;Frantellizzi, Viviana;De Vincentis, Giuseppe;De Berardinis, Ettore
Penultimo
;
Sciarra, Alessandro
Ultimo
2021

Abstract

To get better insight into the management of non-metastatic castration-resistant prostate cancer (M0 CRPC), in this meta-analysis and review we aimed to present an updated evaluation of the efficacy and safety of novel hormonal therapies (nHT) for M0 CRPC according to final analyses with mature overall survival (OS) and safety data.
2021
adverse events; hormonal therapy; metastasis; non-metastatic castration-resistant prostate cancer; overall survival; prostate neoplasm
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data / Maggi, Martina; Salciccia, Stefano; Del Giudice, Francesco; Busetto, Gian Maria; Falagario, Ugo G; Carrieri, Giuseppe; Ferro, Matteo; Porreca, Angelo; Di Pierro, Giovanni Battista; Fasulo, Vittorio; Frantellizzi, Viviana; De Vincentis, Giuseppe; De Berardinis, Ettore; Sciarra, Alessandro. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 11:(2021). [10.3389/fonc.2021.700258]
File allegati a questo prodotto
File Dimensione Formato  
Maggi_Systematic-review_2021.pdf

accesso aperto

Note: https://www.frontiersin.org/articles/10.3389/fonc.2021.700258/full
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.39 MB
Formato Adobe PDF
2.39 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1556803
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact